Medication consent
Informed Consent for Treatment with Orencia (abatacept)
Informed consent for treatment with Orencia.
About this form
Orencia (abatacept) is approved for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis. It works by selectively modulating T-cell activation, a key driver of autoimmune inflammation.
- !Increased risk of serious infections; do not start with active infection.
- !Avoid combining with TNF blockers due to additive infection risk.
- !TB testing recommended prior to therapy.
- !COPD patients may experience worsening respiratory symptoms.
- !Live vaccines should be avoided during therapy and for 3 months after.
Trouble with the form?
Call our office and we'll either walk you through it or send a paper version.